3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Technetium: new trials by email Literature Review of Technetium trials Research Report on Technetium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer 99mTc-3PRGD2 injection - Lung Cancer, Lymph Node Metastasis | Phase 3 | Completed | RDO Pharm. | 409 | 2019-10-12 | 2024-07-01 |
| Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer indocyanine green, isotope - Breast Neoplasms | Phase 3 | Completed | Centre Hospitalier Universitaire de Saint Etienne | 99 | 2014-11-01 | 2018-04-09 |
| Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) regadenoson, overencapsulated caffeine, technetium - Coronary Artery Disease (CAD) | Phase 3 | Completed | Astellas Pharma Inc | 347 | 2009-03-24 | 2024-12-03 |
Breast Neoplasms (1) · Coronary Artery Disease (1) · Ischemia (1) · Lung Neoplasms (1) · Lymphatic Metastasis (1)
Astellas Pharma Inc (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · RDO Pharm. (1)
China (1) · France (1) · United States (1)
2014 (1)